V
ariceal bleeding is the most common cause of serious upper gastrointestinal (UGI) bleeding in children. Most variceal bleeding is esophageal. Hemorrhages from esophageal varices due to portal hypertension are a major cause of morbidity and mortality. There with recurrent variceal hemorrhage. Moreover, the one year survival rate after variceal hemorrhage is caused by portal hypertension, an emergent case in the Pediatric Gastrohepatology division. (Figure 1 ).
Case Report
duct and enlarged spleen. The USG suggested hepatic cirrhosis, splenomegaly, and portal hypertension. The with widening of the vascular diameter (Figure 2) . The bile duct and gallbladder were normal in size, and no gallstones were observed. However, the gall bladder wall was thickened. Pancreas and kidneys appeared normal.
hypertension diagnoses. Confirmation of the diagnosis of hepatic cirrhosis by liver biopsy was not performed due to lack of parental consent. On the second day of hospitalization, the patient had 500 ml of bloody emesis. She was somnolent, (Figure 3) . The esophagus appeared hyperemic and eroded, with bleeding and stigmas present. Endoscopy showed grade III esophageal varices. Sclerotherapy endoscopy (STE) was performed to prevent subsequent rupture of the varices (Figure 4) .
Based on the data above, it was concluded that the patient had ruptured esophageal varices due to portal hypertension related to liver cirrhosis. Differential diagnoses included portal vein thrombosis and idiopathic portal hypertension. The patient was and lactulose. Her vital signs, urination, and fluid balances were strictly monitored. A nasogastric tube was inserted to remove blood from the gastrointestinal tract. Blood gas analysis, electrolytes, random blood glucose examinations, and blood cultures were pCO 88 mmHg, HCO 3 3.6 mg/dL) were also normal. Endoscopic examination was done after the discharged after 30 days of hospitalization. No bleeding was observed during a second STE. Upon discharge the patient was afebrile and able to eat soft foods. Her vital signs were normal. Her liver was not palpable and her ambulatory department was suggested. Fourteen months after discharge, the patient had recurrent hematemesis and was rehospitalized in M. th th normal limits. PT and aPTT were also normal. She received whole blood transfusion, octreotide drip, daily). Repeat abdominal USG revealed liver cirrhosis and splenomegaly. Endoscopy showed grade II and III esophageal varices. STE was repeated. The patient was subsequently discharged in stable condition.
Discussion
with hematemesis caused by ruptured esophageal varices due to portal hypertension. The diagnosis was based on history taking, physical examination, laboratory and radiology findings. It was confirmed by endoscopy.
The patient had acute, massive, and recurrent hematemesis, not preceeded by abdominal pain. She had no history of taking erosive medications. Physical examination showed splenomegaly. There were no signs of bleeding on the skin, gums, or other sites, and there was no lymph node enlargement. Therefore, we excluded the diagnosis of upper gastrointestinal (UGI) bleeding caused by hemorrhagic disease. Review of lit erature suggests that any child with hematemesis and splenomegaly should be presumed to have esophageal variceal bleeding due to portal hypertension until proven otherwise. portal hypertension hemorrhage before 5 years of age,
The patient had slightly abnormal liver function and tested negatively for hepatitis markers. She had no family history of jaundice or liver disease. The Both modalities are considered to be highly sensitive in diagnosing liver cirrhosis. She appeared to have had compensated cirrhosis. Liver biopsy and angiography would have confirmed the diagnoses of liver cirrhosis, and portal vein thrombosis, respectively, but these tests could not be performed due to parents' refusal to consent.
Differential diagnoses of portal hypertension caused by portal vein thrombosis or idiopathic portal hypertension were excluded based on the presence of signs and symptoms of liver cirrhosis. Patients with idiopathic portal hypertension and portal vein thrombosis may be recognized during routine physical examinations if they have splenomegaly in the absence of liver abnormalities.
The patient underwent STE to halt the hemorrhaging of the bleeding varices. She was also given octreotide to stop acute bleeding. The combination of sclerotherapy and octreotide is more effective than sclerotherapy alone. 8 Propranolol was given to prevent recurrence of bleeding. A combination of STE and drug therapy reduces future variceal bleeding better than drug therapy alone. In patients with high risk esophageal variceal bleeding, endoscopic ligation of the varices is safer and more effective than propranolol for the prevention of future variceal bleeding.
